IL71601A - Pharmaceutical compositions comprising co-dergocrine and a calcium antagonist of the 4-aryl-3,5-disubstituted-1,4-dihydropyridine type - Google Patents

Pharmaceutical compositions comprising co-dergocrine and a calcium antagonist of the 4-aryl-3,5-disubstituted-1,4-dihydropyridine type

Info

Publication number
IL71601A
IL71601A IL71601A IL7160184A IL71601A IL 71601 A IL71601 A IL 71601A IL 71601 A IL71601 A IL 71601A IL 7160184 A IL7160184 A IL 7160184A IL 71601 A IL71601 A IL 71601A
Authority
IL
Israel
Prior art keywords
dergocrine
disubstituted
aryl
pharmaceutical compositions
calcium antagonist
Prior art date
Application number
IL71601A
Other languages
English (en)
Other versions
IL71601A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL71601A0 publication Critical patent/IL71601A0/xx
Publication of IL71601A publication Critical patent/IL71601A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
IL71601A 1983-04-22 1984-04-20 Pharmaceutical compositions comprising co-dergocrine and a calcium antagonist of the 4-aryl-3,5-disubstituted-1,4-dihydropyridine type IL71601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22

Publications (2)

Publication Number Publication Date
IL71601A0 IL71601A0 (en) 1984-07-31
IL71601A true IL71601A (en) 1988-12-30

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71601A IL71601A (en) 1983-04-22 1984-04-20 Pharmaceutical compositions comprising co-dergocrine and a calcium antagonist of the 4-aryl-3,5-disubstituted-1,4-dihydropyridine type

Country Status (27)

Country Link
US (2) US4617306A (fr)
JP (1) JPS59205318A (fr)
AT (1) AT393625B (fr)
AU (1) AU571218B2 (fr)
BE (1) BE899434A (fr)
CA (1) CA1218932A (fr)
CH (1) CH658992A5 (fr)
CY (1) CY1499A (fr)
DD (1) DD217712A5 (fr)
DK (1) DK165965C (fr)
FR (1) FR2544614B1 (fr)
GB (1) GB2138678B (fr)
GR (1) GR81973B (fr)
HK (1) HK100289A (fr)
HU (1) HU192050B (fr)
IE (1) IE57468B1 (fr)
IL (1) IL71601A (fr)
IT (1) IT1199114B (fr)
LU (1) LU85331A1 (fr)
MY (1) MY100397A (fr)
NL (1) NL188891C (fr)
NZ (1) NZ207917A (fr)
PH (1) PH20922A (fr)
PT (1) PT78455B (fr)
SE (1) SE465751B (fr)
SG (1) SG53889G (fr)
ZA (1) ZA842993B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159604B1 (fr) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Préparation à libération retardée applicable aux muqueuses de la cavité buccale
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (fr) * 1966-06-24 1967-10-16
SE351565B (fr) * 1967-08-17 1972-12-04 Sandoz Ag
DK154606C (da) * 1975-05-31 1989-05-01 Sandoz Ag Fremgangsmaade til fremstilling af en stabil oploesning af et hydrogeneret meldroejealkaloid
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Also Published As

Publication number Publication date
ATA133784A (de) 1991-05-15
DD217712A5 (de) 1985-01-23
IE57468B1 (en) 1993-01-27
AU2712084A (en) 1984-10-25
NZ207917A (en) 1988-05-30
JPH0564124B2 (fr) 1993-09-14
US4797404A (en) 1989-01-10
NL188891C (nl) 1992-11-02
SE8402199D0 (sv) 1984-04-19
LU85331A1 (fr) 1984-11-28
SG53889G (en) 1989-12-08
NL8401155A (nl) 1984-11-16
PH20922A (en) 1987-06-05
AT393625B (de) 1991-11-25
JPS59205318A (ja) 1984-11-20
US4617306A (en) 1986-10-14
HK100289A (en) 1989-12-29
CY1499A (en) 1990-08-03
GB2138678A (en) 1984-10-31
HUT37889A (en) 1986-03-28
HU192050B (en) 1987-05-28
IT1199114B (it) 1988-12-30
GB2138678B (en) 1986-11-05
ZA842993B (en) 1985-11-27
GB8410363D0 (en) 1984-05-31
MY100397A (en) 1990-09-17
BE899434A (fr) 1984-10-16
AU571218B2 (en) 1988-04-14
DK165965B (da) 1993-02-22
PT78455B (en) 1986-05-27
CA1218932A (fr) 1987-03-10
SE8402199L (sv) 1984-10-23
PT78455A (en) 1984-05-01
CH658992A5 (de) 1986-12-31
IL71601A0 (en) 1984-07-31
IT8448082A0 (it) 1984-04-20
IE840977L (en) 1984-10-22
DK201884D0 (da) 1984-04-18
GR81973B (fr) 1984-12-12
DK201884A (da) 1984-10-23
SE465751B (sv) 1991-10-28
DK165965C (da) 1993-07-26
FR2544614B1 (fr) 1987-08-21
FR2544614A1 (fr) 1984-10-26

Similar Documents

Publication Publication Date Title
GB2136807B (en) Pharmaceutical compositions
GB8423339D0 (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
GB8313217D0 (en) Pharmaceutical compositions
GB8423799D0 (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
GB8325496D0 (en) Pharmaceutical compositions
GB8427485D0 (en) Pharmaceutical compositions
GB8407180D0 (en) Pharmaceutical compositions
IL71187A0 (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions containing them
IL72725A (en) Stigmast-3beta-yloxyphosphorylcholine and analogues thereof,their manufacture and pharmaceutical compositions containing them
ZA844352B (en) Pharmaceutical compositions
CY1503A (en) Pharmaceutical compositions
PT79152A (en) Pharmaceutical compositions
IL71601A (en) Pharmaceutical compositions comprising co-dergocrine and a calcium antagonist of the 4-aryl-3,5-disubstituted-1,4-dihydropyridine type
GB8406132D0 (en) Pharmaceutical compositions
GB2145626B (en) Anti-ulcerogenic pharmaceutical compositions
GB8416358D0 (en) Pharmaceutical compositions
GB8425250D0 (en) Pharmaceutical compositions
GB2150435B (en) Pharmaceutical compositions
ZA843254B (en) Pharmaceutical compositions
GB8331425D0 (en) Pharmaceutical compositions
GB8323623D0 (en) Pharmaceutical compositions
GB8317469D0 (en) Pharmaceutical compositions
IE830600L (en) Pharmaceutical compositions